A Panel-Based Approach to the Diagnosis of Genetic Nephropathies Utilizing Next G
利用 Next G 诊断遗传性肾病的基于面板的方法
基本信息
- 批准号:8781824
- 负责人:
- 金额:$ 14.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-24 至 2015-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeBiological AssayBiopsyBiopsy SpecimenCategoriesChronicChronic Kidney FailureClinicalComputer softwareCorrelation StudiesDNADevelopmentDiabetic NephropathyDiagnosisDiagnosticDiseaseEnd stage renal failureEtiologyExonsFutureGene MutationGenesGeneticGenetic screening methodGenotypeIndustryInheritedInjuryKidneyKidney DiseasesKidney FailureLabelLeadMolecular AbnormalityMutationNephrologyNephrosclerosisNephrotic SyndromePathway interactionsPatientsPhasePhenotypePriceRenal Replacement TherapySamplingSteroid ResistanceTechnologyTestingTimeUnited StatesValidationWorkbasecohortcostdisease diagnosisgene panelnext generation sequencingoutcome forecastpublic health relevance
项目摘要
DESCRIPTION (provided by applicant): There are currently mutations in over 200 genes that have been described to cause kidney disease. Current strategies for diagnosis of genetic kidney disease are extremely costly and time consuming. We aim to develop a comprehensive next generation sequencing panel that can simultaneously test for all currently described kidney- associated gene mutations at a low price within approximately 2 weeks. There are currently no comprehensive gene panels commercially available in the field of nephrology. We believe this assay will greatly decrease turnaround time and cost for the diagnosis of disease. Once the nephrology gene panel is developed, we will use it to describe genotypic-phenotypic correlations in a large cohort of patients with unexplained chronic kidney disease. We will isolate
DNA from de-identified renal biopsy samples and use these samples for target enrichment, amplification and labeling of the exons of genes in our panel followed by sequencing on a MiSeq. We will work closely with DNAStar, makers of an industry-leading sequencing software package, in development of a software pipeline for the assay targeted towards clinical next generation sequencing. Upon completion and validation we will offer the test as a CLIA-certified assay for the diagnosis of hereditary kidney disease.
描述(由申请人提供):目前有超过200个基因突变已被描述为导致肾脏疾病。目前用于诊断遗传性肾病的策略极其昂贵且耗时。我们的目标是开发一个全面的下一代测序面板,可以同时测试所有目前描述的肾脏相关的基因突变,在大约2周内以低廉的价格。目前在肾脏病学领域没有商业上可获得的综合基因面板。我们相信这种检测方法将大大减少疾病诊断的周转时间和成本。一旦肾脏病基因组被开发出来,我们将用它来描述一个大型的不明原因慢性肾脏病患者队列的基因型-表型相关性。我们将隔离
从去识别的肾活检样品中提取DNA,并使用这些样品进行靶富集、扩增和标记我们的组中的基因外显子,然后在MiSeq上测序。我们将与行业领先的测序软件包制造商DNAStar密切合作,开发针对临床下一代测序的检测软件管道。在完成和验证后,我们将提供作为CLIA认证的检测方法,用于诊断遗传性肾病。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher P Larsen其他文献
Christopher P Larsen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher P Larsen', 18)}}的其他基金
A proprietary digital platform for precision patient identification and enrollment of clinical trials for rare kidney diseases
用于精确识别患者和注册罕见肾脏疾病临床试验的专有数字平台
- 批准号:
10822581 - 财政年份:2023
- 资助金额:
$ 14.34万 - 项目类别:
Development of specific peptide reagents for serologic monitoring of Exostosin autoantibodies in membranous lupus nephritis
膜性狼疮肾炎外骨蛋白自身抗体血清学监测特异性肽试剂的开发
- 批准号:
10545924 - 财政年份:2022
- 资助金额:
$ 14.34万 - 项目类别:
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
膜性肾病精准医学诊断工具的开发
- 批准号:
10703484 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Rapid Genotyping of ApoL1 Risk Alleles using CRISPR-Cas12a
使用 CRISPR-Cas12a 对 ApoL1 风险等位基因进行快速基因分型
- 批准号:
10384222 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
膜性肾病精准医学诊断工具的开发
- 批准号:
10324016 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Development of a Precision Medicine-based Diagnostic Tool for Membranous Nephropathy
膜性肾病精准医学诊断工具的开发
- 批准号:
10602134 - 财政年份:2021
- 资助金额:
$ 14.34万 - 项目类别:
Development of biomarkers for improved classification of membranous lupus nephritis
开发生物标志物以改进膜性狼疮性肾炎的分类
- 批准号:
9796488 - 财政年份:2019
- 资助金额:
$ 14.34万 - 项目类别:
相似海外基金
Establishment of a new biological assay using Hydra nematocyst deployment
利用水螅刺丝囊部署建立新的生物测定方法
- 批准号:
520728-2017 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
University Undergraduate Student Research Awards
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10368760 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
10669539 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9570142 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER) AFTER RADIOLOGICAL AND NUCLEAR EVENTS.
用于确定放射和核事件后组织特异性吸收电离辐射剂量(生物剂量计)的护理点生物测定。
- 批准号:
9915803 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
COVID-19 Supplemental work: POINT-OF-CARE BIOLOGICAL ASSAY FOR DETERMINING TISSUE-SPECIFIC ABSORBED IONIZING RADIATION DOSE (BIODOSIMETER).
COVID-19 补充工作:用于确定组织特异性吸收电离辐射剂量的护理点生物测定(生物剂量计)。
- 批准号:
10259999 - 财政年份:2017
- 资助金额:
$ 14.34万 - 项目类别:
Drug discovery based on a new biological assay system using Yeast knock-out strain collection
基于使用酵母敲除菌株收集的新生物测定系统的药物发现
- 批准号:
21580130 - 财政年份:2009
- 资助金额:
$ 14.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2005
- 资助金额:
$ 14.34万 - 项目类别:
Postdoctoral Fellowships
Machine learning for automatic gene annotation using high-throughput biological assay data
使用高通量生物测定数据进行自动基因注释的机器学习
- 批准号:
300985-2004 - 财政年份:2004
- 资助金额:
$ 14.34万 - 项目类别:
Postdoctoral Fellowships